Furthermore, all RAF1 fusion proteins identified in pediatric CNS tumors have N-terminal partners that possess a coiled-coil or other dimerization domain, meaning they belong to type I of kinase fusions (Fig. 2b). This evidence concerns the gene RAF1 and central nervous system neoplasm.